CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 4 Grant or award Chief Financial Officer acquired 140,000 shares (grant or award)
- 4 Grant or award Chief Scientific & Dev. Ofc. acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP of Corp. Dev. acquired 20,000 shares (grant or award)
- 4 Grant or award SVP of Finance acquired 40,000 shares (grant or award)
- 4 Shares withheld for taxes SVP of Finance gave up 3,950 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,282 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Corp. Dev. gave up 4,031 shares (to pay taxes)
- 4 Grant or award Director acquired 14,964 shares (grant or award)
- 4 Grant or award Director acquired 22,090 shares (grant or award)
- 4 Grant or award Director acquired 24,762 shares (grant or award)
- 4 Grant or award Director acquired 19,418 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 49,692 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 400,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 6 of 21 · 403 filings